Medika d.d. Statistics
Total Valuation
Medika d.d. has a market cap or net worth of EUR 131.45 million. The enterprise value is 147.91 million.
| Market Cap | 131.45M |
| Enterprise Value | 147.91M |
Important Dates
The last earnings date was Friday, February 27, 2026.
| Earnings Date | Feb 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Medika d.d. has 28,954 shares outstanding.
| Current Share Class | 28,954 |
| Shares Outstanding | 28,954 |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 6.06% |
| Owned by Institutions (%) | 0.36% |
| Float | 404 |
Valuation Ratios
The trailing PE ratio is 4.73.
| PE Ratio | 4.73 |
| Forward PE | n/a |
| PS Ratio | 0.14 |
| PB Ratio | 0.86 |
| P/TBV Ratio | 1.37 |
| P/FCF Ratio | 11.28 |
| P/OCF Ratio | 6.17 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.22, with an EV/FCF ratio of 12.69.
| EV / Earnings | 5.32 |
| EV / Sales | 0.16 |
| EV / EBITDA | 5.22 |
| EV / EBIT | 6.65 |
| EV / FCF | 12.69 |
Financial Position
The company has a current ratio of 1.17, with a Debt / Equity ratio of 0.28.
| Current Ratio | 1.17 |
| Quick Ratio | 0.90 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | 1.52 |
| Debt / FCF | 3.62 |
| Interest Coverage | 10.28 |
Financial Efficiency
Return on equity (ROE) is 20.03% and return on invested capital (ROIC) is 9.90%.
| Return on Equity (ROE) | 20.03% |
| Return on Assets (ROA) | 2.54% |
| Return on Invested Capital (ROIC) | 9.90% |
| Return on Capital Employed (ROCE) | 12.55% |
| Weighted Average Cost of Capital (WACC) | 3.41% |
| Revenue Per Employee | 882,874 |
| Profits Per Employee | 25,750 |
| Employee Count | 1,079 |
| Asset Turnover | 1.79 |
| Inventory Turnover | 8.67 |
Taxes
In the past 12 months, Medika d.d. has paid 6.00 million in taxes.
| Income Tax | 6.00M |
| Effective Tax Rate | 17.76% |
Stock Price Statistics
The stock price has decreased by -18.93% in the last 52 weeks. The beta is -0.19, so Medika d.d.'s price volatility has been lower than the market average.
| Beta (5Y) | -0.19 |
| 52-Week Price Change | -18.93% |
| 50-Day Moving Average | 4,777.80 |
| 200-Day Moving Average | 5,254.80 |
| Relative Strength Index (RSI) | 38.48 |
| Average Volume (20 Days) | 11 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medika d.d. had revenue of EUR 952.62 million and earned 27.78 million in profits. Earnings per share was 959.62.
| Revenue | 952.62M |
| Gross Profit | 55.49M |
| Operating Income | 21.68M |
| Pretax Income | 33.79M |
| Net Income | 27.78M |
| EBITDA | 27.79M |
| EBIT | 21.68M |
| Earnings Per Share (EPS) | 959.62 |
Balance Sheet
The company has 25.73 million in cash and 42.19 million in debt, with a net cash position of -16.46 million or -568.33 per share.
| Cash & Cash Equivalents | 25.73M |
| Total Debt | 42.19M |
| Net Cash | -16.46M |
| Net Cash Per Share | -568.33 |
| Equity (Book Value) | 152.68M |
| Book Value Per Share | 5,273.04 |
| Working Capital | 71.29M |
Cash Flow
In the last 12 months, operating cash flow was 21.32 million and capital expenditures -9.67 million, giving a free cash flow of 11.65 million.
| Operating Cash Flow | 21.32M |
| Capital Expenditures | -9.67M |
| Depreciation & Amortization | 6.11M |
| Net Borrowing | 6.65M |
| Free Cash Flow | 11.65M |
| FCF Per Share | 402.47 |
Margins
Gross margin is 5.82%, with operating and profit margins of 2.28% and 2.92%.
| Gross Margin | 5.82% |
| Operating Margin | 2.28% |
| Pretax Margin | 3.55% |
| Profit Margin | 2.92% |
| EBITDA Margin | 2.92% |
| EBIT Margin | 2.28% |
| FCF Margin | 1.22% |
Dividends & Yields
Medika d.d. does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 21.14% |
| FCF Yield | 8.87% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Medika d.d. has an Altman Z-Score of 2.4 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.4 |
| Piotroski F-Score | 4 |